I recently had a great discussion with Andrew Bish and Chad Frey of the Taking Root hemp podcast. We discussed a number of topics, including FDA claims and how hemp and CBD companies can weather the current financial storm.
Category: Hemp and CBD
Medical Cannabis Clinical Evidence Is Becoming Immune To State Borders
A physician’s education about cannabis medicine, and her patient’s treatment options, should not depend on their state of residence. Patient access should be based on sound science and physicians should receive comprehensive and uniform education regardless of the state in which they practice.
NC State University Promotes Hemp In Recent Article
This month’s NC State University magazine features hemp on its cover and includes a story about hemp in NC. I am pleased that it mentions several of my clients and provides a helpful overview of the impact that hemp is having on state and national economies.
Rod Discusses USDA Hemp Regulation with New Frontier Data (Video)
I had a great time discussing the USDA’s hemp regulations with John Kagia and Jake Sitler on April 22, 2020. The webinar was hosted by New Frontier Data. You can watch it here.
Do Not Claim That Your CBD Helps With COVID-19
It is good to see the FDA taking quick and firm action against companies improperly marketing their CBD products as effective against COVID-19, a devastating pandemic with no contemporary precedent.
Want to Read the Latest Edition of the American Journal of Endocannabinoid Medicine?
The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.
Concerned About Coronavirus and Your Cannabis Business? We’d Like to Help.
As a service to our current clients and readers during these difficult times, we are offering a free 20-minute phone call to address your pressing issues – no strings attached.
Rod Discusses US and EU CBD Regulations at Europe Canna Expo-Dublin
For my talk, I compared and contrasted the hemp and CBD regulatory regimes in Europe and US. Although they parallel each other in some respects, particularly policy, they are fundamentally different in their approaches.
FDA Responds to Congress and Seeks Guidance About CBD
The FDA has yet to create a regulatory pathway for CBD. Does its most recent report to Congress herald a change?